SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-22-000003
Filing Date
2022-02-09
Accepted
2022-02-09 13:00:20
Documents
83
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20211231x10q.htm   iXBRL 10-Q 2418655
2 EX-31.1 veru-20211231xex31_1.htm EX-31.1 15661
3 EX-31.2 veru-20211231xex31_2.htm EX-31.2 15886
4 EX-32.1 veru-20211231xex32_1.htm EX-32.1 12011
  Complete submission text file 0000863894-22-000003.txt   6533981

Data Files

Seq Description Document Type Size
5 EX-101.SCH veru-20211231.xsd EX-101.SCH 58515
6 EX-101.CAL veru-20211231_cal.xml EX-101.CAL 71279
7 EX-101.DEF veru-20211231_def.xml EX-101.DEF 208905
8 EX-101.LAB veru-20211231_lab.xml EX-101.LAB 460655
9 EX-101.PRE veru-20211231_pre.xml EX-101.PRE 395021
77 EXTRACTED XBRL INSTANCE DOCUMENT veru-20211231x10q_htm.xml XML 367679
Mailing Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127
Business Address 48 NW 25TH STREET SUITE 102 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 22605478
SIC: 2834 Pharmaceutical Preparations